SCHEMBL8402469

SCHEMBL8402469

COC(=O)Cc1ccc(OCC(C)NCC(O)c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 10/20 0.53
▸ ADRB3 P13945 9/20 0.53
▸ ADRB2 P07550 7/20 0.53
▸ GLA P06280 2/20 0.53
▸ ALOX15 P16050 1/20 0.51
▸ ADRA1D P25100 2/20 0.49
▸ ADRA1A P35348 2/20 0.49
▸ ADRA1B P35368 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ TDP1 Q9NUW8 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8406379 1.00 ADRB1 (0.53) ADRB1ADRB3ADRB2GLAALOX15
SCHEMBL8406923 1.00 ADRB1 (0.53) ADRB1ADRB3ADRB2GLAALOX15
SCHEMBL8406383 1.00 ADRB1 (0.53) ADRB1ADRB3ADRB2GLAALOX15
SCHEMBL8405956 1.00 ADRB1 (0.53) ADRB1ADRB3ADRB2GLAALOX15
SCHEMBL8405107 0.90 ADRB3 (0.54) ADRB1ADRB3ADRB2GLAADRA1D
SCHEMBL8402453 0.89 ADRB1 (0.61) ADRB1ADRB3ADRB2GLAADRA1D
SCHEMBL8405786 0.89 ADRB2 (0.54) ADRB1ADRB3ADRB2GLAADRA1D
SCHEMBL8405970 0.88 ADRB2 (0.56) ADRB1ADRB3ADRB2GLAADRA1D
SCHEMBL8406234 0.88 ADRB2 (0.56) ADRB1ADRB3ADRB2GLAADRA1D
SCHEMBL8402264 0.88 CYP2D6 (0.53) ADRB1ADRB3ADRB2GLAADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5635534-A 1-PHENYL-2-(2-PHENYLOXY OR THIO)-1-METHYLETHYL)AMINOETHANOL DERIVATIVES; ALDOSE REDUCTASE INHIBITORS; NONTOXIC; ANTIDIABETIC,-OBESITY,-LIPEMIC AND HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-06-03 — — US claimed
EP-0543662-B1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO CO (JP) 1996-09-18 — — EP claimed
EP-0543662-A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-05-26 — — EP claimed
US-5977374-A 5-(4-hydroxy-OR 4-acetoxy-benzyl)-3- triphenylmethylthiazolidine-2,4-dione and method for producing same SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5635534-A 1-PHENYL-2-(2-PHENYLOXY OR THIO)-1-METHYLETHYL)AMINOETHANOL DERIVATIVES; ALDOSE REDUCTASE INHIBITORS; NONTOXIC; ANTIDIABETIC,-OBESITY,-LIPEMIC AND HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-06-03 — — US disclosed
US-5576340-A Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 1996-11-19 — — US disclosed
EP-0543662-B1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO CO (JP) 1996-09-18 — — EP disclosed
EP-0543662-A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-05-26 — — EP disclosed
Send feedback